The clinical value of the serum cobalamin concentration as a highly sensitive After boiling and cooling, 500 mg/l colistin sulphate (or 2 g/l colistimethate sodium) was added. Broth was dispensed in 20 ml aliquots into glass screw-capped containers and stored at -20'C. A culture of L leichmannii was started by resuspension of freeze dried organism (or cryopreserved culture) in one of these broths and incubation overnight (37°C). This growth was subcultured for two successive days by adding 10 p1 to a second broth (20 ml) each morning and incubating overnight. This procedure was essential to ensure that the culture was well established. The percentage survival of viable organisms, and their subsequent response under assay conditions, depends on the growth phase at the time of freezing. Cells in the log phase give the best response.6 Cultures are prepared as follows. On the morning after the third overnight incubation 2 ml of culture was added to each of two fresh broths. These broths were incubated in parallel, and turbidity in one (at 595 nm) was monitored hourly in a Beckman model 35 spectrophotometer (Beckman, High Wycombe, Buckinghamshire). When growth reached the log phase (after about eight hours) an equal volume of sterile glycerol (800 ml/l) was then added to the other culture. It was mixed thoroughly and dispensed in 1 ml aliquots into microtubes. These were placed in a polystyrene box with walls 1 cm thick, frozen down, and stored at -70'C. These cultures are stable for many months. 6 The organism may also be maintained by serial subculture and prepared as described previously.5 ASSAY PROCEDURE Extracts of patient serum (see above) and control sera were dispensed (2 x 100 pl and 2 x 50 Ml) into microtitre plate wells using a "Stepper" automatic pipette. Compensating volumes (50 p1) of extraction buffer were added to the wells containing 50 p1 of extract. Thus each serum extract is assayed at two dilutions in duplicate. A standard curve was prepared in quadruplicate; it comprised a range of cyanocobalamin concentrations from 0-5 pg/well. An additional four wells were set aside at the zero point as an uninoculated blank. Compensating volumes of extraction buffer were added as appropriate to bring all well volumes to 100
Ml. Assay medium was prepared by dissolving 6 2 g of dried vitamin B12 assay broth base and 150 pl of Tween 80 in each 100 ml of water. After the medium was boiled and cooled colistin sulphate (11 mg/100 ml) was added (or colistimethate sodium 44 mg/100 ml). A phial of cryopreserved organism was rapidly thawed (37'C) and added to the cooled medium (200 pl/ 100 ml of medium). After thorough mixing on a magnetic stirrer 200 p1 of inoculated medium was added to every well, using an eight-channel pipette. Blanks to zero the plate reader were created by adding 10 pl of a 4% solution of Stericol disinfectant to the extra set of wells at the zero point of the standard curve. The addition ofdisinfectant had the effect ofpreventing organism growth without contributing to the optical density of the blank. Each plate was covered with a plate sealer, mixed by inversion, and incubated at 37'C. After 20 hours the contents were resuspended by inversion, the plate sealers removed, and each plate was read at 595 nm on the plate reader. A standard curve was constructed (fig 1) and the vitamin B12 concentrations of the unknowns calculated.
COMPARISON WITH TUBE ASSAY
The assay as performed on microtitre plates was compared with a more traditional "tube" assay. The "tube" assay was based on that of Kelleher et al 5 and incorporated the use of the cryopreserved organism. 6 The results of 580 serum samples were compared.
ASSAY PERFORMANCE
Control sera were used to determine the reproducibility of the new assay. These five sera were assayed 10 times in one assay and once in 10 different assays to determine within-and between-assay precision. The analytical recovery of added cyanocobalamin was also determined after additions of 100 ng/l, 200 ng/l, 300 ng/l, 400 ng/l and 500 ng/l of cyanocobalamin (n = 10 in each case) to a serum with a low vitamin B,2 concentration.
SAMPLES CONTAINING ANTIBIOTIC
An analysis of 3291 vitamin B12 microbiological assays using the tube assay7 had shown that those antibiotics which caused interference were almost exclusively of the fl-lactam type (penicillins or cephalosporins). The study showed that antibiotic interference could be virtually eliminated by pre-treating sera with a /3-lactamase preparation. As the incidence of antibiotic interference in this plate assay was similar (9%) it was important to evaluate the effectiveness ofsuch treatment. Sera containing interfering antibiotics were identified by the fact that either no growth occurred in the microtitre plate wells at all, or that the higher dilution of serum extract gave the higher result (because it contained less antibiotic). These sera were treated with ,B-lactamase. Each phial of enzyme (700 units/phial) was reconstituted with 5 ml of distilled water. Although stable for only seven days at 4°C, reconstituted enzyme may be stored in aliquots at -20'C for many weeks. The effectiveness of,-lactamase in treating samples affected by antibiotics was evaluated by measuring the recovery of a "spike" of cyanocobalamin added to each Kelleher The performance data for interassay variations are shown in table 1 values range from 1 2 to 3 5 % for th variation, and from 1 9 to 4 3% fo assay series. Analytical recovery cobalamin using this assay was excl 2), with recovery values ranging fro 102-1% of added cyanocobalamin.õ f the serum vitamin B12 resul antibiotic-containing samples aftei with ,B-lactamase was verified by c the percentage recovery of a cyan spike (tube C). The mean recove fig 2. The primarily due to the speed of absorbance readr = 0-983, p ing offered by modern automated microtitre iven by the plate readers when compared with the tedium of reading each tube of a "tube" assay on a and intra-spectrophotometer. The CV%
The assay performs well in the laboratory. A ke interassay comparison with the previous "tube" assay ir the intra-showed good correlation (r = 0 98, p < 0 001).
of cyano-Cyanocobalamin can be quantitatively ellent (table recovered (table 2) , and the precision, both )m 94-85%-between and within assay is excellent (table 1). rhe validity The limit of detectability of the assay is below Its for the 20 ng/l, and adaptations can easily be made to r treatment provide accurate results in duplicate on very letermining small serum volumes (< 50 p,l). A previous Locobalamin study in this laboratory had shown that ry from 84 pretreatment of sera with a /3-lactamase preparation was effective in eliminating the interference of penicillins, cephalosporins, and values as Augmentin before serum vitamin B12 assay. 7 We included a similar step for antibioticcontaining samples in this assay and this also proved effective, with a valid result obtained on all 84 routine such samples tested. This result was verified by the recovery of 100-18% (CV 13-95%) of a cyanocobalamin "spike" added to the samples. We now find it cost effective to pretreat all assay samples with / 
